{"entity":{"type":"insider","cik":"0001376847","url":"/insider/0001376847","json_url":"/insider/0001376847.json","name":"O'Connor Daniel J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":19,"first":"2013-10-28","last":"2023-10-31","span_basis":"filed_date"},"name_variants":[{"name":"O'Connor Daniel J.","source":"filing","n_filings":11,"first_seen":"2018-02-06","last_seen":"2023-10-31"},{"name":"O'Connor Daniel","source":"filing","n_filings":8,"first_seen":"2013-10-28","last_seen":"2016-11-02"}],"transactions":[{"id":8040320,"accession":"0000950170-23-056943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-056943","line_url":"/filing/0000950170-23-056943#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"Ambrx Biopharma, Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50012.0,"shares_display":"50,012","price_per_share":9.82,"price_display":"9.82","price_state":"stated","total_value":491117.84,"total_display":"491,117.84","shares_owned_after":342845.0,"shares_owned_after_display":"342,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-27","filed_date":"2023-10-31","scope":"insider"},{"id":6748133,"accession":"0001136261-22-000249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001136261-22-000249","line_url":"/filing/0001136261-22-000249#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"SEELOS THERAPEUTICS, INC.","issuer_ticker":"SEEL","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":0.6118,"price_display":"0.61","price_state":"stated","total_value":9788.8,"total_display":"9,788.80","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":4232638,"accession":"0001493152-21-010454","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-010454","line_url":"/filing/0001493152-21-010454#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3172.0,"shares_display":"3,172","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":15415.92,"total_display":"15,415.92","shares_owned_after":96097.0,"shares_owned_after_display":"96,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-05-04","scope":"insider"},{"id":4789072,"accession":"0001493152-21-002424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-002424","line_url":"/filing/0001493152-21-002424#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3413.0,"shares_display":"3,413","price_per_share":7.71,"price_display":"7.71","price_state":"stated","total_value":26314.23,"total_display":"26,314.23","shares_owned_after":99269.0,"shares_owned_after_display":"99,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-02","scope":"insider"},{"id":2610585,"accession":"0001493152-20-020427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-020427","line_url":"/filing/0001493152-20-020427#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3280.0,"shares_display":"3,280","price_per_share":3.79,"price_display":"3.79","price_state":"stated","total_value":12431.2,"total_display":"12,431.20","shares_owned_after":102682.0,"shares_owned_after_display":"102,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":3103224,"accession":"0001493152-20-014643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-014643","line_url":"/filing/0001493152-20-014643#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3133.0,"shares_display":"3,133","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":13158.6,"total_display":"13,158.60","shares_owned_after":105962.0,"shares_owned_after_display":"105,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-31","filed_date":"2020-08-04","scope":"insider"},{"id":2161259,"accession":"0001493152-20-007676","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-007676","line_url":"/filing/0001493152-20-007676#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3075.0,"shares_display":"3,075","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":5504.25,"total_display":"5,504.25","shares_owned_after":62986.0,"shares_owned_after_display":"62,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-04","scope":"insider"},{"id":2156903,"accession":"0001493152-20-001537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-001537","line_url":"/filing/0001493152-20-001537#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2654.0,"shares_display":"2,654","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":5201.84,"total_display":"5,201.84","shares_owned_after":66061.0,"shares_owned_after_display":"66,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-31","filed_date":"2020-02-03","scope":"insider"},{"id":8266940,"accession":"0001493152-19-016362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-19-016362","line_url":"/filing/0001493152-19-016362#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2128.0,"shares_display":"2,128","price_per_share":2.16,"price_display":"2.16","price_state":"stated","total_value":4596.48,"total_display":"4,596.48","shares_owned_after":68715.0,"shares_owned_after_display":"68,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-01","scope":"insider"},{"id":6531521,"accession":"0001493152-18-015311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-18-015311","line_url":"/filing/0001493152-18-015311#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":9100.0,"total_display":"9,100.00","shares_owned_after":26667.0,"shares_owned_after_display":"26,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-07","scope":"insider"},{"id":6704098,"accession":"0001493152-18-001498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-18-001498","line_url":"/filing/0001493152-18-001498#line-1","is_derivative":false,"issuer_cik":"0001376847","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001376847","owner_cik":"0001376847","owner_name":"O'Connor Daniel J.","owner_url":"/insider/0001376847","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16667.0,"shares_display":"16,667","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":25000.5,"total_display":"25,000.50","shares_owned_after":16667.0,"shares_owned_after_display":"16,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-06","scope":"insider"},{"id":2615752,"accession":"0001493152-16-014442","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-16-014442","line_url":"/filing/0001493152-16-014442#line-3","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8240.0,"shares_display":"8,240","price_per_share":8.32,"price_display":"8.32","price_state":"stated","total_value":68556.8,"total_display":"68,556.80","shares_owned_after":294656.0,"shares_owned_after_display":"294,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-02","filed_date":"2016-11-02","scope":"insider"},{"id":3191861,"accession":"0001493152-16-009321","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-16-009321","line_url":"/filing/0001493152-16-009321#line-3","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8237.0,"shares_display":"8,237","price_per_share":7.51,"price_display":"7.51","price_state":"stated","total_value":61859.87,"total_display":"61,859.87","shares_owned_after":307817.0,"shares_owned_after_display":"307,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-02","filed_date":"2016-05-02","scope":"insider"},{"id":2570942,"accession":"0001493152-16-007071","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-16-007071","line_url":"/filing/0001493152-16-007071#line-3","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8818.0,"shares_display":"8,818","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":60667.84,"total_display":"60,667.84","shares_owned_after":313394.0,"shares_owned_after_display":"313,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-29","filed_date":"2016-02-01","scope":"insider"},{"id":8891628,"accession":"0001493152-15-005109","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-15-005109","line_url":"/filing/0001493152-15-005109#line-3","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8350.0,"shares_display":"8,350","price_per_share":12.26,"price_display":"12.26","price_state":"stated","total_value":102371.0,"total_display":"102,371.00","shares_owned_after":331733.0,"shares_owned_after_display":"331,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-30","filed_date":"2015-11-03","scope":"insider"},{"id":8221852,"accession":"0001493152-15-003360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-15-003360","line_url":"/filing/0001493152-15-003360#line-3","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8449.0,"shares_display":"8,449","price_per_share":15.44,"price_display":"15.44","price_state":"stated","total_value":130452.56,"total_display":"130,452.56","shares_owned_after":338856.0,"shares_owned_after_display":"338,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-31","filed_date":"2015-08-04","scope":"insider"},{"id":6773360,"accession":"0001144204-14-020114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-020114","line_url":"/filing/0001144204-14-020114#line-1","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3333.0,"shares_display":"3,333","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":9999.0,"total_display":"9,999.00","shares_owned_after":311016.0,"shares_owned_after_display":"311,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-31","filed_date":"2014-04-02","scope":"insider"},{"id":9236397,"accession":"0001144204-13-057499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-057499","line_url":"/filing/0001144204-13-057499#line-1","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13500.0,"shares_display":"13,500","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":54000.0,"total_display":"54,000.00","shares_owned_after":61336.0,"shares_owned_after_display":"61,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-24","filed_date":"2013-10-29","scope":"insider"},{"id":5443887,"accession":"0001144204-13-057263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-057263","line_url":"/filing/0001144204-13-057263#line-1","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001376847","owner_name":"O'Connor Daniel","owner_url":"/insider/0001376847","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13500.0,"shares_display":"13,500","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":54000.0,"total_display":"54,000.00","shares_owned_after":61256.0,"shares_owned_after_display":"61,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-24","filed_date":"2013-10-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001990550","name":"Ambrx Biopharma, Inc.","url":"/issuer/0001990550","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2023-10-31","last_seen":"2023-10-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001017491","name":"SEELOS THERAPEUTICS, INC.","url":"/issuer/0001017491","role":"Director","n_filings":1,"first_seen":"2022-06-02","last_seen":"2022-06-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001444307","name":"ONCOSEC MEDICAL Inc","url":"/issuer/0001444307","role":"Director, Officer (CEO and President)","n_filings":9,"first_seen":"2018-02-06","last_seen":"2021-05-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001100397","name":"Advaxis, Inc.","url":"/issuer/0001100397","role":"Director, Officer (Chief Executive Officer)","n_filings":8,"first_seen":"2013-10-28","last_seen":"2016-11-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001376847","retrieved_at":"2026-08-20T23:35:15+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}